Indicators
Indicators
Value
Direction
MACD(12,26,9)
-0.113
Sell
RSI(14)
44.627
Neutral
STOCH(KDJ)(9,3,3)
37.925
Buy
ATR(14)
0.426
Low Volatility
CCI(14)
-26.428
Neutral
Williams %R
57.436
Sell
TRIX(12,20)
-0.247
Sell
StochRSI(14)
100.000
Overbought
Fresenius Medical Care AG
FMS22.250USD
-0.140-0.63%
Market hours （ET）Quotes delayed by 15 min
6.21BMarket Cap
11.75P/E TTM
TradingKey Stock Score
Overall Financial Health
Valuation Dimensions
Earnings Forecast
Price Momentum
Institutional Confidence
Risk Assessment
Peer Comparison
TradingKey Stock Score of Fresenius Medical Care AG
Currency: USD Updated: 2026-03-26Key Insights
Fresenius Medical Care AG's fundamentals are relatively healthy, with an industry-leading ESG disclosure.and its growth potential is high.Its valuation is considered fairly valued, ranking 45 out of 75 in the Healthcare Providers & Services industry.Institutional ownership is very high.Over the past month, multiple analysts have rated it as Hold, with the highest price target at 26.43.In the medium term, the stock price is expected to remain stable.Despite an average stock market performance over the past month, the company shows strong fundamentals and technicals.The stock price is trading sideways between the support and resistance levels, making it suitable for range-bound swing trading.
Fresenius Medical Care AG's Score
Support & Resistance
Relevant data have not been disclosed by the company yet.
Score Analysis
Current score
Previous score
Media Coverage
Last 24 hours
Coverage Level
Very Low
Very High
Neutral
Fresenius Medical Care AG Highlights
StrengthsRisks
Fresenius Medical Care AG, formerly Fresenius Medical Care AG & Co. KGaA is a Germany-based kidney dialysis institute. The Company provides dialysis care and related services to persons suffering from end-stage renal disease (ESRD) and offers other extracorporeal therapies, as well as other healthcare services. It has two operating segments such as care delivery segment which consolidates the global health care services business and care enablement segment includes research and development (R&D), manufacturing, supply chain, and commercial operations. It develops and manufactures health care products, which includes dialysis and non-dialysis products. Such as hemodialysis machines, peritoneal cyclers, dialyzers, peritoneal solutions and granulates, bloodlines, renal pharmaceuticals, and systems for water treatment. Its non-dialysis products include acute cardiopulmonary and apheresis products. It owns, operates, or manages dialysis clinics sells products to other dialysis providers.
High Profit Growth
The company's net income leads the industry, with the latest annual income totaling USD 22.13B.
High Dividend
The company is a high dividend payer, with the latest dividend payout ratio of 78.64%.
Stable Dividend
The company has regularly paid dividends over the past 5 years, with the latest dividend payout ratio of 78.64%.
Undervalued
The company’s latest PE is 11.82, at a low 3-year percentile range.
Held by Barrow Hanley
Star Investor Barrow Hanley holds 155.10K shares of this stock.
Analyst Rating
Based on
7
analysts
Hold
Current Rating
26.425
Target Price
+19.95%
Upside Space
Data disclaimer: Analyst ratings and target prices are provided by LSEG for informational purposes only and do not constitute investment advice.
Financial Health
Currency: USD Updated: 2026-03-26The current financial score of Fresenius Medical Care AG is 8.36, ranking 14 out of 75 in the Healthcare Providers & Services industry. Its financial status is stable, and its operating efficiency is high. Its latest quarterly revenue reached 5.90B, representing a year-over-year increase of 8.82%, while its net profit experienced a year-over-year increase of 433.64%.
Score
Financials
6.38
Key Metrics
Cash and cash equivalents
Total assets
Total liabilities
Free cash flow
Relevant data have not been disclosed by the company yet.
Quality of Earnings
9.23
Operational Efficiency
8.30
Growth Potential
8.49
Shareholder Returns
9.38
Fresenius Medical Care AG's Company Valuation
Currency: USD Updated: 2026-03-26The current valuation score of Fresenius Medical Care AG is 6.28, ranking 54 out of 75 in the Healthcare Providers & Services industry. Its current P/E ratio is 11.82, which is 123.27% below the recent high of 26.39 and 3.35% above the recent low of 11.42.
Score
Valuation Dimensions
P/E
P/B
P/S
P/CF
Industry Ranking 45/75
Relevant data have not been disclosed by the company yet.
Earnings Forecast
Currency: USD Updated: 2026-03-26The current earnings forecast score of Fresenius Medical Care AG is 5.14, ranking 67 out of 75 in the Healthcare Providers & Services industry. The average price target is 28.00, with a high of 39.65 and a low of 20.70.
Score
Support & Resistance
Relevant data have not been disclosed by the company yet.
Analyst Rating
Based on
7
analysts
Hold
Current Rating
26.425
Target Price
+19.95%
Upside Space
Strong Buy
Buy
Hold
Sell
Strong Sell
Peer Comparison
68
Total
7
Median
9
Average
Company name
Ratings
Analysts
Fresenius Medical Care AG
FMS
7
CVS Health Corp
CVS
29
HCA Healthcare Inc
HCA
27
Teladoc Health Inc
TDOC
27
Tenet Healthcare Corp
THC
24
Natera Inc
NTRA
22
1
2
3
...
14
Financial Forecasting
EPS
Revenue
Net Profit
EBIT
Relevant data have not been disclosed by the company yet.
Data disclaimer: Analyst ratings and target prices are provided by LSEG for informational purposes only and do not constitute investment advice.
Price Momentum
Currency: USD Updated: 2026-03-26The current price momentum score of Fresenius Medical Care AG is 7.00, ranking 24 out of 75 in the Healthcare Providers & Services industry. Currently, the stock price is trading between the resistance level at 23.45 and the support level at 21.45, making it suitable for range-bound swing trading.
Score
Support & Resistance
Relevant data have not been disclosed by the company yet.
Indicators
The Indicators feature provides value and direction analysis for various instruments under a selection of technical indicators, together with a technical summary.
This feature includes nine of the commonly used technical indicators: MACD, RSI, KDJ, StochRSI, ATR, CCI, WR, TRIX and MA. You may also adjust the timeframe depending on your needs.
Please note that technical analysis is only part of investment reference, and there is no absolute standard for using numerical values to assess direction. The results are for reference only, and we are not responsible for the accuracy of the indicator calculations and summaries.
Moving Average
Indicators
Value
Direction
MA5
22.044
Buy
MA10
22.370
Sell
MA20
22.745
Sell
MA50
22.962
Sell
MA100
23.326
Sell
MA200
24.816
Sell
Institutional Confidence
Currency: USD Updated: 2026-03-26The current institutional shareholding score of Fresenius Medical Care AG is 3.00, ranking 59 out of 75 in the Healthcare Providers & Services industry. The latest institutional shareholding proportion is 8.10%, representing a quarter-over-quarter decrease of 0.22%. The largest institutional shareholder is Richard Pzena, holding a total of 14.75M shares, representing 2.64% of shares outstanding, with 0.79% increase in holdings.
Score
Institutional Shareholding
Relevant data have not been disclosed by the company yet.
Shareholder Activity
Name
Shares Held
Chg %
Wellington Management Company, LLP
Fiduciary Management, Inc.
Todd Asset Management LLC
Aristotle Capital Management, LLC
Morgan Stanley & Co. International Plc
Parametric Portfolio Associates LLC
1
2
Risk Assessment
Currency: USD Updated: 2026-03-26The U.S. Dollar Index is currently in a neutral state, which has a neutral effect on the Healthcare Providers & Services domestic-focused industry. The Dollar Index (DXY) measures the value of the U.S. dollar against a basket of major currencies, including the euro, yen, pound sterling, Canadian dollar, Swedish krona, and Swiss franc. The current risk assessment score of Fresenius Medical Care AG is 8.29, ranking 15 out of 75 in the Healthcare Providers & Services industry. The company's beta value is 0.88. This indicates that the stock tends to underperform the index during upward trending markets but experiences smaller declines during downward trending markets. with an industry-leading ESG disclosure.
Score
Beta vs S&P 500 index
0.88
VaR
+3.20%
240-Day Maximum Drawdown
+29.28%
240-Day Volatility
+28.69%
Return
Best Daily Return
60 days
+3.61%
120 days
+3.63%
5 years
+11.19%
Worst Daily Return
60 days
-7.85%
120 days
-7.85%
5 years
-17.57%
Sharpe Ratio
60 days
-0.74
120 days
-1.08
5 years
-0.18
Risk Assessment
Maximum Drawdown
240 days
+29.28%
3 years
+40.49%
5 years
+69.59%
Return-to-Drawdown Ratio
240 days
-0.21
3 years
-0.05
5 years
-0.13
Skewness
240 days
-0.83
3 years
-0.91
5 years
-0.82
Volatility
Realised Volatility
240 days
+28.69%
5 years
+32.34%
Standardised True Range
240 days
+2.18%
5 years
+2.32%
Downside Risk-Adjusted Return
120 days
-118.44%
240 days
-118.44%
Maximum Daily Upside Volatility
60 days
+27.98%
Maximum Daily Downside Volatility
60 days
+31.00%
Liquidity
Average Turnover Rate
60 days
+0.11%
120 days
+0.13%
5 years
--
Turnover Deviation
20 days
-20.05%
60 days
-18.29%
120 days
+1.53%
Peer Comparison
Healthcare Providers & Services
Fresenius Medical Care AG
FMS
6.59 /10
Score
Financial Health
Valuation Dimensions
Earnings Forecast
Price Momentum
Institutional Confidence
Risk Assessment
Brightspring Health Services Inc
BTSG
8.24 /10
Score
Financial Health
Valuation Dimensions
Earnings Forecast
Price Momentum
Institutional Confidence
Risk Assessment
Pediatrix Medical Group Inc
MD
8.16 /10
Score
Financial Health
Valuation Dimensions
Earnings Forecast
Price Momentum
Institutional Confidence
Risk Assessment
Natera Inc
NTRA
8.14 /10
Score
Financial Health
Valuation Dimensions
Earnings Forecast
Price Momentum
Institutional Confidence
Risk Assessment
Encompass Health Corp
EHC
8.11 /10
Score
Financial Health
Valuation Dimensions
Earnings Forecast
Price Momentum
Institutional Confidence
Risk Assessment
Ensign Group Inc
ENSG
8.09 /10
Score
Financial Health
Valuation Dimensions
Earnings Forecast
Price Momentum
Institutional Confidence
Risk Assessment
View more
